Cargando…

Suppression of epithelial abnormalities by nintedanib in induced-rheumatoid arthritis-associated interstitial lung disease mouse model

Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is relevant for the prognosis in patients with RA. Nintedanib, which inhibits both receptor and non-receptor type tyrosine kinases, is an antifibrotic drug for the treatment of progressive fibrosing ILDs, such as idiopathic pulmonary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miura, Yoko, Ohkubo, Hirotsugu, Niimi, Akio, Kanazawa, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646002/ https://www.ncbi.nlm.nih.gov/pubmed/34881329 http://dx.doi.org/10.1183/23120541.00345-2021

Ejemplares similares

Nintedanib induces gene expression changes in the lung of induced-rheumatoid arthritis–associated interstitial lung disease mice
por: Mikami, Shintaro, et al.
Publicado: (2022)

Summer‐type hypersensitivity pneumonitis in a patient with rheumatoid arthritis on methotrexate and tacrolimus
por: Ohkubo, Hirotsugu, et al.
Publicado: (2016)

A successful treatment of rheumatoid arthritis-related interstitial pneumonia with nintedanib
por: Kakuwa, Tamaki, et al.
Publicado: (2018)

Remarkable Improvement in a Patient with Idiopathic Pulmonary Fibrosis after Treatment with Nintedanib
por: Nakano, Akiko, et al.
Publicado: (2018)

Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease
por: Vacchi, Caterina, et al.
Publicado: (2020)

Effect of H(2) treatment in a mouse model of rheumatoid arthritis‐associated interstitial lung disease
por: Terasaki, Yasuhiro, et al.
Publicado: (2019)

Therapeutic effect of nintedanib on acute exacerbation of interstitial lung diseases
por: Ito, Yoko, et al.
Publicado: (2019)

Spontaneous improvement of interstitial pneumonia with autoimmune features: A case report
por: Ohkubo, Hirotsugu, et al.
Publicado: (2021)

Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung
por: Miura, Yoko, et al.
Publicado: (2022)

Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia
por: Miura, Yoko, et al.
Publicado: (2021)

Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease
por: Madgula, Anantha Sriharsha, et al.
Publicado: (2020)

Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
por: Lamb, Yvette N.
Publicado: (2021)

Nintedanib in children and adolescents with fibrosing interstitial lung diseases
por: Deterding, Robin, et al.
Publicado: (2023)

Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new
por: Leone, Paolo Maria, et al.
Publicado: (2020)

Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
por: Wollin, Lutz, et al.
Publicado: (2019)

Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
por: Cottin, Vincent, et al.
Publicado: (2021)

Effects of nintedanib by inclusion criteria for progression of interstitial lung disease
por: Maher, Toby M., et al.
Publicado: (2022)

Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
por: Lamb, Yvette N.
Publicado: (2021)

Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature review
por: Suzuki, Ayana, et al.
Publicado: (2023)

Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease triggered by COVID-19: What is the best practice for treatment?
por: Yonezawa, Toshiyuki, et al.
Publicado: (2023)

Osteochondrogenesis derived from synovial fibroblasts in inflammatory arthritis model
por: Miura, Yoko, et al.
Publicado: (2020)

CTLA-4-Ig internalizes CD80 in fibroblast-like synoviocytes from chronic inflammatory arthritis mouse model
por: Miura, Yoko, et al.
Publicado: (2022)

Normal Lung Quantification in Usual Interstitial Pneumonia Pattern: The Impact of Threshold-based Volumetric CT Analysis for the Staging of Idiopathic Pulmonary Fibrosis
por: Ohkubo, Hirotsugu, et al.
Publicado: (2016)

Rheumatoid arthritis-associated interstitial lung disease
por: Solomon, Joshua J, et al.
Publicado: (2012)

Correction: Normal Lung Quantification in Usual Interstitial Pneumonia Pattern: The Impact of Threshold-based Volumetric CT Analysis for the Staging of Idiopathic Pulmonary Fibrosis
por: Ohkubo, Hirotsugu, et al.
Publicado: (2016)

Exposure–safety analyses of nintedanib in patients with chronic fibrosing interstitial lung disease
por: Schmid, Ulrike, et al.
Publicado: (2021)

Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial
por: Flaherty, Kevin R., et al.
Publicado: (2022)

Interstitial Lung Disease in Rheumatoid Arthritis in the Era of Biologics
por: Picchianti Diamanti, A., et al.
Publicado: (2011)

The Multifaceted Aspects of Interstitial Lung Disease in Rheumatoid Arthritis
por: Cavagna, Lorenzo, et al.
Publicado: (2013)

Management of the Rheumatoid Arthritis Patient with Interstitial Lung Disease
por: Jani, Meghna, et al.
Publicado: (2017)

Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease
por: Kim, Yerin, et al.
Publicado: (2023)

Early clinical experiences with nintedanib in three UK tertiary interstitial lung disease centres
por: Toellner, Hannah, et al.
Publicado: (2017)

Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
por: Westerink, Lotte, et al.
Publicado: (2022)

Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases
por: Bonella, Francesco, et al.
Publicado: (2022)

Nintedanib administration after the onset of acute exacerbation of interstitial lung disease in the real world
por: Kato, Motoyasu, et al.
Publicado: (2023)

Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial
por: Matteson, Eric L., et al.
Publicado: (2023)

Emphysema and Interstitial Pneumonia in Rheumatoid Arthritis
por: Sakai, Fumikazu
Publicado: (2018)

Bronchial epithelial gene expression and interstitial lung abnormalities
por: Menon, Aravind A., et al.
Publicado: (2023)

High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities
por: Salaffi, Fausto, et al.
Publicado: (2019)

Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
por: Hozumi, Hironao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2akij6ilfvhda9i6rl4lee45ma